All In Biotech

Free tool

FAERS Monitor: Ozempic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213051 or its brand name (Ozempic, Semaglutide). Reports on generic versions are filed under their own applications.

Reports

78,023

Serious

39,105

50% of reports

Hospitalization

15,565

Death reported

1,364

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea11,150
  • off label use7,890
  • vomiting7,332
  • diarrhoea6,833
  • decreased appetite5,107
  • constipation4,976
  • weight decreased4,777
  • impaired gastric emptying4,175
  • product use in unapproved indication3,761
  • blood glucose increased3,460
  • fatigue3,252
  • headache3,240
  • abdominal pain upper3,197
  • wrong technique in product usage process3,100
  • weight increased2,869

Reports by year received

View as table
YearReports
20132
20143
20157
201614
201714
20181,142
20191,596
20203,514
20214,563
20226,320
20239,506
202414,313
202520,019
202617,010

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,136 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
impaired gastric emptyingSignal4,175118.5114.4337,774
constipationSignal4,9766.36.121,763
decreased appetiteSignal5,1076.05.921,226
blood glucose increasedSignal3,4605.04.911,043
weight decreasedSignal4,7774.74.513,746
vomitingSignal7,3324.34.218,377
abdominal pain upperSignal3,1974.24.17,854
wrong technique in product usage processSignal3,1004.24.07,432
product use in unapproved indicationSignal3,7614.14.08,918
nauseaSignal11,1503.83.823,965
weight increasedSignal2,8693.53.45,071
diarrhoeaSignal6,8332.92.88,517
off label useSignal7,8902.42.46,946
headache3,2401.41.3371
fatigue3,2521.11.148

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.